Loading…

Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane

Paclitaxel (PTX) is one of the most effective antineoplastic drugs employed for breast and ovarian cancer therapy. However, the neurotoxicity associated with PTX administration represents one of its main drawbacks reducing patient life quality. Recently, curcumin (CUR) has been explored as a neuropr...

Full description

Saved in:
Bibliographic Details
Published in:Journal of drug delivery science and technology 2021-04, Vol.62, p.102343, Article 102343
Main Authors: Riedel, Jennifer, Calienni, Maria Natalia, Bernabeu, Ezequiel, Calabro, Valeria, Lázaro-Martinez, Juan Manuel, Prieto, Maria Jimena, Gonzalez, Lorena, Martinez, Carolina Soledad, Alonso, Silvia del Valle, Montanari, Jorge, Evelson, Pablo, Chiappetta, Diego A., Moretton, Marcela A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53
cites cdi_FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53
container_end_page
container_issue
container_start_page 102343
container_title Journal of drug delivery science and technology
container_volume 62
creator Riedel, Jennifer
Calienni, Maria Natalia
Bernabeu, Ezequiel
Calabro, Valeria
Lázaro-Martinez, Juan Manuel
Prieto, Maria Jimena
Gonzalez, Lorena
Martinez, Carolina Soledad
Alonso, Silvia del Valle
Montanari, Jorge
Evelson, Pablo
Chiappetta, Diego A.
Moretton, Marcela A.
description Paclitaxel (PTX) is one of the most effective antineoplastic drugs employed for breast and ovarian cancer therapy. However, the neurotoxicity associated with PTX administration represents one of its main drawbacks reducing patient life quality. Recently, curcumin (CUR) has been explored as a neuroprotective agent due to its antioxidant properties. Then, the co-encapsulation of PTX and CUR in a mixed micellar formulation could promote a neuroprotective effect of the micellar system and optimize breast and ovarian cancer therapy. PTX-CUR-loaded Soluplus:TPGS mixed micelles were developed and characterized by nuclear magnetic resonance, scattering techniques and transmission electron microscopy. In vitro cytotoxicity was evaluated in MDA-MB-231 and SKOV-3 cancer cells. The in vitro antioxidant performance of CUR-loaded nanoformulations was confirmed employing lipid peroxidation inhibition and DPPH colorimetric assays. The neuroprotective effect of the micellar formulations was evaluated on zebrafish larvae. Mixed micelles demonstrated an excellent colloidal stability, before and after freeze-drying. Nanoformulations with both drugs demonstrated the best in vitro anticancer performance versus the commercially available nanoformulation Abraxane® in breast and ovarian cancer cells lines. The in vitro antioxidant properties of the mixed micelles with CUR were confirmed and their in vivo potential neuroprotective effect was assessed in the zebrafish model. [Display omitted] •The hydrophobic PTX and CUR were successfully loaded in mixed micelles.•Drug-loaded nanoformulations showed better in vitro cytotoxicity than Abraxane®.•Mixed micelles with PTX and CUR showed in vitro antioxidant properties.•PTX-CUR-mixed micelles demonstrated neuroprotective effect in a zebrafish model.
doi_str_mv 10.1016/j.jddst.2021.102343
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_jddst_2021_102343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1773224721000241</els_id><sourcerecordid>S1773224721000241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53</originalsourceid><addsrcrecordid>eNp9kM1qwzAQhHVooSHNE_SiF3CqH9uyCz2E0J9AoD20ZyGvVkHGsYOkBPft6yQ997ILszvD8BHywNmSM14-tsvW2piWggk-KULm8obMuFIyEyJXd2QRY8sY44rxXNQzkj4NdD6ZETtqekvhGOC49z2FIesGY9HSvR8vE7DrMD7Rzf4QhpPvd3R6O_kUBorOeTDwc4kIaI9wPqdh9ODTpO6M72OiqyaY0fR4T26d6SIu_vacfL--fK3fs-3H22a92mYgmUyZLFWRV6KulUVXN0wB1K60jTKVcqIpweWQM1cY41ytsCqqhlknkEuTlwoKOSfymgthiDGg04fg9yb8aM70mZdu9YWXPvPSV16T6_nqwqnayWPQETz2gNYHhKTt4P_1_wLJEXlr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane</title><source>ScienceDirect Freedom Collection</source><creator>Riedel, Jennifer ; Calienni, Maria Natalia ; Bernabeu, Ezequiel ; Calabro, Valeria ; Lázaro-Martinez, Juan Manuel ; Prieto, Maria Jimena ; Gonzalez, Lorena ; Martinez, Carolina Soledad ; Alonso, Silvia del Valle ; Montanari, Jorge ; Evelson, Pablo ; Chiappetta, Diego A. ; Moretton, Marcela A.</creator><creatorcontrib>Riedel, Jennifer ; Calienni, Maria Natalia ; Bernabeu, Ezequiel ; Calabro, Valeria ; Lázaro-Martinez, Juan Manuel ; Prieto, Maria Jimena ; Gonzalez, Lorena ; Martinez, Carolina Soledad ; Alonso, Silvia del Valle ; Montanari, Jorge ; Evelson, Pablo ; Chiappetta, Diego A. ; Moretton, Marcela A.</creatorcontrib><description>Paclitaxel (PTX) is one of the most effective antineoplastic drugs employed for breast and ovarian cancer therapy. However, the neurotoxicity associated with PTX administration represents one of its main drawbacks reducing patient life quality. Recently, curcumin (CUR) has been explored as a neuroprotective agent due to its antioxidant properties. Then, the co-encapsulation of PTX and CUR in a mixed micellar formulation could promote a neuroprotective effect of the micellar system and optimize breast and ovarian cancer therapy. PTX-CUR-loaded Soluplus:TPGS mixed micelles were developed and characterized by nuclear magnetic resonance, scattering techniques and transmission electron microscopy. In vitro cytotoxicity was evaluated in MDA-MB-231 and SKOV-3 cancer cells. The in vitro antioxidant performance of CUR-loaded nanoformulations was confirmed employing lipid peroxidation inhibition and DPPH colorimetric assays. The neuroprotective effect of the micellar formulations was evaluated on zebrafish larvae. Mixed micelles demonstrated an excellent colloidal stability, before and after freeze-drying. Nanoformulations with both drugs demonstrated the best in vitro anticancer performance versus the commercially available nanoformulation Abraxane® in breast and ovarian cancer cells lines. The in vitro antioxidant properties of the mixed micelles with CUR were confirmed and their in vivo potential neuroprotective effect was assessed in the zebrafish model. [Display omitted] •The hydrophobic PTX and CUR were successfully loaded in mixed micelles.•Drug-loaded nanoformulations showed better in vitro cytotoxicity than Abraxane®.•Mixed micelles with PTX and CUR showed in vitro antioxidant properties.•PTX-CUR-mixed micelles demonstrated neuroprotective effect in a zebrafish model.</description><identifier>ISSN: 1773-2247</identifier><identifier>DOI: 10.1016/j.jddst.2021.102343</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Breast and ovarian cancer ; Curcumin ; Mixed micelles ; Paclitaxel ; Soluplus ; Zebrafish</subject><ispartof>Journal of drug delivery science and technology, 2021-04, Vol.62, p.102343, Article 102343</ispartof><rights>2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53</citedby><cites>FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53</cites><orcidid>0000-0002-7189-6874 ; 0000-0001-7605-3449 ; 0000-0002-0575-7833 ; 0000-0002-9177-0240 ; 0000-0001-8776-3307</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Riedel, Jennifer</creatorcontrib><creatorcontrib>Calienni, Maria Natalia</creatorcontrib><creatorcontrib>Bernabeu, Ezequiel</creatorcontrib><creatorcontrib>Calabro, Valeria</creatorcontrib><creatorcontrib>Lázaro-Martinez, Juan Manuel</creatorcontrib><creatorcontrib>Prieto, Maria Jimena</creatorcontrib><creatorcontrib>Gonzalez, Lorena</creatorcontrib><creatorcontrib>Martinez, Carolina Soledad</creatorcontrib><creatorcontrib>Alonso, Silvia del Valle</creatorcontrib><creatorcontrib>Montanari, Jorge</creatorcontrib><creatorcontrib>Evelson, Pablo</creatorcontrib><creatorcontrib>Chiappetta, Diego A.</creatorcontrib><creatorcontrib>Moretton, Marcela A.</creatorcontrib><title>Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane</title><title>Journal of drug delivery science and technology</title><description>Paclitaxel (PTX) is one of the most effective antineoplastic drugs employed for breast and ovarian cancer therapy. However, the neurotoxicity associated with PTX administration represents one of its main drawbacks reducing patient life quality. Recently, curcumin (CUR) has been explored as a neuroprotective agent due to its antioxidant properties. Then, the co-encapsulation of PTX and CUR in a mixed micellar formulation could promote a neuroprotective effect of the micellar system and optimize breast and ovarian cancer therapy. PTX-CUR-loaded Soluplus:TPGS mixed micelles were developed and characterized by nuclear magnetic resonance, scattering techniques and transmission electron microscopy. In vitro cytotoxicity was evaluated in MDA-MB-231 and SKOV-3 cancer cells. The in vitro antioxidant performance of CUR-loaded nanoformulations was confirmed employing lipid peroxidation inhibition and DPPH colorimetric assays. The neuroprotective effect of the micellar formulations was evaluated on zebrafish larvae. Mixed micelles demonstrated an excellent colloidal stability, before and after freeze-drying. Nanoformulations with both drugs demonstrated the best in vitro anticancer performance versus the commercially available nanoformulation Abraxane® in breast and ovarian cancer cells lines. The in vitro antioxidant properties of the mixed micelles with CUR were confirmed and their in vivo potential neuroprotective effect was assessed in the zebrafish model. [Display omitted] •The hydrophobic PTX and CUR were successfully loaded in mixed micelles.•Drug-loaded nanoformulations showed better in vitro cytotoxicity than Abraxane®.•Mixed micelles with PTX and CUR showed in vitro antioxidant properties.•PTX-CUR-mixed micelles demonstrated neuroprotective effect in a zebrafish model.</description><subject>Breast and ovarian cancer</subject><subject>Curcumin</subject><subject>Mixed micelles</subject><subject>Paclitaxel</subject><subject>Soluplus</subject><subject>Zebrafish</subject><issn>1773-2247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kM1qwzAQhHVooSHNE_SiF3CqH9uyCz2E0J9AoD20ZyGvVkHGsYOkBPft6yQ997ILszvD8BHywNmSM14-tsvW2piWggk-KULm8obMuFIyEyJXd2QRY8sY44rxXNQzkj4NdD6ZETtqekvhGOC49z2FIesGY9HSvR8vE7DrMD7Rzf4QhpPvd3R6O_kUBorOeTDwc4kIaI9wPqdh9ODTpO6M72OiqyaY0fR4T26d6SIu_vacfL--fK3fs-3H22a92mYgmUyZLFWRV6KulUVXN0wB1K60jTKVcqIpweWQM1cY41ytsCqqhlknkEuTlwoKOSfymgthiDGg04fg9yb8aM70mZdu9YWXPvPSV16T6_nqwqnayWPQETz2gNYHhKTt4P_1_wLJEXlr</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Riedel, Jennifer</creator><creator>Calienni, Maria Natalia</creator><creator>Bernabeu, Ezequiel</creator><creator>Calabro, Valeria</creator><creator>Lázaro-Martinez, Juan Manuel</creator><creator>Prieto, Maria Jimena</creator><creator>Gonzalez, Lorena</creator><creator>Martinez, Carolina Soledad</creator><creator>Alonso, Silvia del Valle</creator><creator>Montanari, Jorge</creator><creator>Evelson, Pablo</creator><creator>Chiappetta, Diego A.</creator><creator>Moretton, Marcela A.</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7189-6874</orcidid><orcidid>https://orcid.org/0000-0001-7605-3449</orcidid><orcidid>https://orcid.org/0000-0002-0575-7833</orcidid><orcidid>https://orcid.org/0000-0002-9177-0240</orcidid><orcidid>https://orcid.org/0000-0001-8776-3307</orcidid></search><sort><creationdate>202104</creationdate><title>Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane</title><author>Riedel, Jennifer ; Calienni, Maria Natalia ; Bernabeu, Ezequiel ; Calabro, Valeria ; Lázaro-Martinez, Juan Manuel ; Prieto, Maria Jimena ; Gonzalez, Lorena ; Martinez, Carolina Soledad ; Alonso, Silvia del Valle ; Montanari, Jorge ; Evelson, Pablo ; Chiappetta, Diego A. ; Moretton, Marcela A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Breast and ovarian cancer</topic><topic>Curcumin</topic><topic>Mixed micelles</topic><topic>Paclitaxel</topic><topic>Soluplus</topic><topic>Zebrafish</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riedel, Jennifer</creatorcontrib><creatorcontrib>Calienni, Maria Natalia</creatorcontrib><creatorcontrib>Bernabeu, Ezequiel</creatorcontrib><creatorcontrib>Calabro, Valeria</creatorcontrib><creatorcontrib>Lázaro-Martinez, Juan Manuel</creatorcontrib><creatorcontrib>Prieto, Maria Jimena</creatorcontrib><creatorcontrib>Gonzalez, Lorena</creatorcontrib><creatorcontrib>Martinez, Carolina Soledad</creatorcontrib><creatorcontrib>Alonso, Silvia del Valle</creatorcontrib><creatorcontrib>Montanari, Jorge</creatorcontrib><creatorcontrib>Evelson, Pablo</creatorcontrib><creatorcontrib>Chiappetta, Diego A.</creatorcontrib><creatorcontrib>Moretton, Marcela A.</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of drug delivery science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riedel, Jennifer</au><au>Calienni, Maria Natalia</au><au>Bernabeu, Ezequiel</au><au>Calabro, Valeria</au><au>Lázaro-Martinez, Juan Manuel</au><au>Prieto, Maria Jimena</au><au>Gonzalez, Lorena</au><au>Martinez, Carolina Soledad</au><au>Alonso, Silvia del Valle</au><au>Montanari, Jorge</au><au>Evelson, Pablo</au><au>Chiappetta, Diego A.</au><au>Moretton, Marcela A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane</atitle><jtitle>Journal of drug delivery science and technology</jtitle><date>2021-04</date><risdate>2021</risdate><volume>62</volume><spage>102343</spage><pages>102343-</pages><artnum>102343</artnum><issn>1773-2247</issn><abstract>Paclitaxel (PTX) is one of the most effective antineoplastic drugs employed for breast and ovarian cancer therapy. However, the neurotoxicity associated with PTX administration represents one of its main drawbacks reducing patient life quality. Recently, curcumin (CUR) has been explored as a neuroprotective agent due to its antioxidant properties. Then, the co-encapsulation of PTX and CUR in a mixed micellar formulation could promote a neuroprotective effect of the micellar system and optimize breast and ovarian cancer therapy. PTX-CUR-loaded Soluplus:TPGS mixed micelles were developed and characterized by nuclear magnetic resonance, scattering techniques and transmission electron microscopy. In vitro cytotoxicity was evaluated in MDA-MB-231 and SKOV-3 cancer cells. The in vitro antioxidant performance of CUR-loaded nanoformulations was confirmed employing lipid peroxidation inhibition and DPPH colorimetric assays. The neuroprotective effect of the micellar formulations was evaluated on zebrafish larvae. Mixed micelles demonstrated an excellent colloidal stability, before and after freeze-drying. Nanoformulations with both drugs demonstrated the best in vitro anticancer performance versus the commercially available nanoformulation Abraxane® in breast and ovarian cancer cells lines. The in vitro antioxidant properties of the mixed micelles with CUR were confirmed and their in vivo potential neuroprotective effect was assessed in the zebrafish model. [Display omitted] •The hydrophobic PTX and CUR were successfully loaded in mixed micelles.•Drug-loaded nanoformulations showed better in vitro cytotoxicity than Abraxane®.•Mixed micelles with PTX and CUR showed in vitro antioxidant properties.•PTX-CUR-mixed micelles demonstrated neuroprotective effect in a zebrafish model.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jddst.2021.102343</doi><orcidid>https://orcid.org/0000-0002-7189-6874</orcidid><orcidid>https://orcid.org/0000-0001-7605-3449</orcidid><orcidid>https://orcid.org/0000-0002-0575-7833</orcidid><orcidid>https://orcid.org/0000-0002-9177-0240</orcidid><orcidid>https://orcid.org/0000-0001-8776-3307</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1773-2247
ispartof Journal of drug delivery science and technology, 2021-04, Vol.62, p.102343, Article 102343
issn 1773-2247
language eng
recordid cdi_crossref_primary_10_1016_j_jddst_2021_102343
source ScienceDirect Freedom Collection
subjects Breast and ovarian cancer
Curcumin
Mixed micelles
Paclitaxel
Soluplus
Zebrafish
title Paclitaxel and curcumin co-loaded mixed micelles: Improving in vitro efficacy and reducing toxicity against Abraxane
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T02%3A12%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paclitaxel%20and%20curcumin%20co-loaded%20mixed%20micelles:%20Improving%20in%20vitro%20efficacy%20and%20reducing%20toxicity%20against%20Abraxane&rft.jtitle=Journal%20of%20drug%20delivery%20science%20and%20technology&rft.au=Riedel,%20Jennifer&rft.date=2021-04&rft.volume=62&rft.spage=102343&rft.pages=102343-&rft.artnum=102343&rft.issn=1773-2247&rft_id=info:doi/10.1016/j.jddst.2021.102343&rft_dat=%3Celsevier_cross%3ES1773224721000241%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c303t-3675482997def9b07cc9f6db7a87f2b6cf4c40f5aaff97e858b0df2e13a467c53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true